TY - JOUR AU - Walter, R. B. AU - Estey, E. H. PY - 2015 DA - 2015// TI - Management of older or unfit patients with acute myeloid leukemia JO - Leukemia VL - 29 UR - https://doi.org/10.1038/leu.2014.216 DO - 10.1038/leu.2014.216 ID - Walter2015 ER - TY - JOUR AU - Oran, B. AU - Weisdorf, D. J. PY - 2012 DA - 2012// TI - Survival for older patients with acute myeloid leukemia: a population-based study JO - Haematologica VL - 97 UR - https://doi.org/10.3324/haematol.2012.066100 DO - 10.3324/haematol.2012.066100 ID - Oran2012 ER - TY - JOUR AU - André, N. AU - Banavali, S. AU - Snihur, Y. AU - Pasquier, E. PY - 2013 DA - 2013// TI - Has the time come for metronomics in low-income and middle-income countries? JO - Lancet Oncol VL - 14 UR - https://doi.org/10.1016/S1470-2045(13)70056-1 DO - 10.1016/S1470-2045(13)70056-1 ID - André2013 ER - TY - JOUR AU - Pongudom, S. AU - Phinyo, P. AU - Chinthammitr, Y. AU - Charoenprasert, K. AU - Kasyanan, H. AU - Wongyai, K. PY - 2020 DA - 2020// TI - Efficacy and safety of metronomic chemotherapy versus palliative hydroxyurea in unfit acute myeloid leukemia patients: a multicenter, open-label randomized controlled trial JO - Asian Pac J Cancer Prev VL - 21 UR - https://doi.org/10.31557/APJCP.2020.21.1.147 DO - 10.31557/APJCP.2020.21.1.147 ID - Pongudom2020 ER - TY - JOUR AU - Royston, P. AU - Parmar, M. K. PY - 2013 DA - 2013// TI - Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome JO - BMC Med Res Methodol VL - 13 UR - https://doi.org/10.1186/1471-2288-13-152 DO - 10.1186/1471-2288-13-152 ID - Royston2013 ER - TY - JOUR AU - Freidlin, B. AU - Korn, E. L. PY - 2019 DA - 2019// TI - Methods for accommodating nonproportional hazards in clinical trials: ready for the primary analysis? JO - J Clin Oncol VL - 37 UR - https://doi.org/10.1200/JCO.19.01681 DO - 10.1200/JCO.19.01681 ID - Freidlin2019 ER - TY - JOUR AU - Gregson, J. AU - Sharples, L. AU - Stone, G. W. AU - Burman, C. -. F. AU - Öhrn, F. AU - Pocock, S. PY - 2019 DA - 2019// TI - Nonproportional hazards for time-to-event outcomes in clinical trials: JACC review topic of the week JO - J Am Coll Cardiol VL - 74 UR - https://doi.org/10.1016/j.jacc.2019.08.1034 DO - 10.1016/j.jacc.2019.08.1034 ID - Gregson2019 ER - TY - JOUR AU - Pak, K. AU - Uno, H. AU - Kim, D. H. AU - Tian, L. AU - Kane, R. C. AU - Takeuchi, M. PY - 2017 DA - 2017// TI - Interpretability of cancer clinical trial results using restricted mean survival time as an alternative to the hazard ratio JO - JAMA Oncol VL - 3 UR - https://doi.org/10.1001/jamaoncol.2017.2797 DO - 10.1001/jamaoncol.2017.2797 ID - Pak2017 ER - TY - JOUR AU - A’Hern, R. P. PY - 2016 DA - 2016// TI - Restricted mean survival time: an obligatory end point for time-to-event analysis in cancer trials? JO - J Clin Oncol Off J Am Soc Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2016.67.8045 DO - 10.1200/JCO.2016.67.8045 ID - A’Hern2016 ER - TY - JOUR AU - Lambert, P. C. AU - Royston, P. PY - 2009 DA - 2009// TI - Further development of flexible parametric models for survival analysis JO - Stata J VL - 9 UR - https://doi.org/10.1177/1536867X0900900206 DO - 10.1177/1536867X0900900206 ID - Lambert2009 ER - TY - JOUR AU - Royston, P. AU - Parmar, M. K. B. PY - 2011 DA - 2011// TI - The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt JO - Stat Med VL - 30 UR - https://doi.org/10.1002/sim.4274 DO - 10.1002/sim.4274 ID - Royston2011 ER - TY - JOUR AU - Royston, P. PY - 2015 DA - 2015// TI - Estimating the treatment effect in a clinical trial using difference in restricted mean survival time JO - Stata J VL - 15 UR - https://doi.org/10.1177/1536867X1501500409 DO - 10.1177/1536867X1501500409 ID - Royston2015 ER - TY - JOUR AU - Lang, K. AU - Earle, C. C. AU - Foster, T. AU - Dixon, D. AU - Gool, R. AU - Menzin, J. PY - 2005 DA - 2005// TI - Trends in the treatment of acute myeloid leukaemia in the elderly JO - Drugs Aging VL - 22 UR - https://doi.org/10.2165/00002512-200522110-00004 DO - 10.2165/00002512-200522110-00004 ID - Lang2005 ER - TY - JOUR AU - Stensrud, M. J. AU - Hernán, M. A. PY - 2020 DA - 2020// TI - Why test for proportional hazards? JO - JAMA VL - 323 UR - https://doi.org/10.1001/jama.2020.1267 DO - 10.1001/jama.2020.1267 ID - Stensrud2020 ER - TY - JOUR AU - Fang, X. AU - Uno, H. AU - Wei, L. -. J. PY - 2018 DA - 2018// TI - Assessing metronomic chemotherapy for progressive pediatric solid malignant tumors JO - JAMA Oncol VL - 4 UR - https://doi.org/10.1001/jamaoncol.2017.3983 DO - 10.1001/jamaoncol.2017.3983 ID - Fang2018 ER - TY - JOUR AU - Uno, H. AU - Claggett, B. AU - Tian, L. AU - Inoue, E. AU - Gallo, P. AU - Miyata, T. PY - 2014 DA - 2014// TI - Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis JO - J Clin Oncol Off J Am Soc Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2014.55.2208 DO - 10.1200/JCO.2014.55.2208 ID - Uno2014 ER - TY - JOUR AU - Trinquart, L. AU - Jacot, J. AU - Conner, S. C. AU - Porcher, R. PY - 2016 DA - 2016// TI - Comparison of treatment effects measured by the hazard ratio and by the ratio of restricted mean survival times in oncology randomized controlled trials JO - J Clin Oncol Off J Am Soc Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2015.64.2488 DO - 10.1200/JCO.2015.64.2488 ID - Trinquart2016 ER - TY - JOUR AU - Gebski, V. AU - Yang, J. C. -. H. AU - Lee, C. K. PY - 2018 DA - 2018// TI - Estimating and interpreting the overall survival benefit of checkpoint inhibitors via meta-analysis—reply JO - JAMA Oncol. VL - 4 UR - https://doi.org/10.1001/jamaoncol.2018.1105 DO - 10.1001/jamaoncol.2018.1105 ID - Gebski2018 ER - TY - JOUR AU - Pramanik, R. AU - Agarwala, S. AU - Gupta, Y. K. AU - Thulkar, S. AU - Vishnubhatla, S. AU - Batra, A. PY - 2017 DA - 2017// TI - Metronomic chemotherapy vs best supportive care in progressive pediatric solid malignant tumors: a randomized clinical trial JO - JAMA Oncol VL - 3 UR - https://doi.org/10.1001/jamaoncol.2017.0324 DO - 10.1001/jamaoncol.2017.0324 ID - Pramanik2017 ER - TY - JOUR AU - Hernán, M. A. PY - 2010 DA - 2010// TI - The hazards of hazard ratios JO - Epidemiol Camb Mass VL - 21 UR - https://doi.org/10.1097/EDE.0b013e3181c1ea43 DO - 10.1097/EDE.0b013e3181c1ea43 ID - Hernán2010 ER -